Literature DB >> 8915905

Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice.

P A Ballenthin1, M V Gardinier.   

Abstract

Myelin/oligodendrocyte glycoprotein (MOG) is an integral membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, MOG is a primary target antigen involved in immune-mediated demyelination. We previously reported that MOG is a unique member of the immunoglobulin (Ig) superfamily in that it possesses two large hydrophobic domains. MOG is highly conserved between deduced peptide sequences of rodent and human MOG (approximately 89% identity). We have completed an investigation of alternative splicing within the human and mouse MOG genes. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of total cellular RNA isolated from both fetal and adult human central nervous system (CNS) tissues reveals a complex array of alternatively spliced MOG-specific variants and the presence of two novel exons. Exon 3 encodes a short hydrophilic domain containing multiple in-frame termination codons that would result in truncation of MOG prior to translation of its transmembrane domain. Exon 7 encodes an additional hydrophilic domain that replaces MOG's second hydrophobic domain in one splice variant. We also observed that five of our eight MOG variants exhibited an alternative internal 3' splice acceptor within MOG's terminal exon. Surprisingly, no splicing was observed in a developmental study using mouse brainstem RNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915905     DOI: 10.1002/(SICI)1097-4547(19961015)46:2<271::AID-JNR16>3.0.CO;2-5

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.

Authors:  Hassnae Afrache; Philippe Gouret; Shanaiz Ainouche; Pierre Pontarotti; Daniel Olive
Journal:  Immunogenetics       Date:  2012-09-23       Impact factor: 2.846

Review 2.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

3.  Altered gene expression in the adult brain of fyn-deficient mice.

Authors:  June Goto; Tohru Tezuka; Takanobu Nakazawa; Nobuo Tsukamoto; Takahisa Nakamura; Rieko Ajima; Kazumasa Yokoyama; Tsutomu Ohta; Misao Ohki; Tadashi Yamamoto
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

4.  Cloning and characterization of the mouse Mcoln1 gene reveals an alternatively spliced transcript not seen in humans.

Authors:  John L Falardeau; John C Kennedy; James S Acierno; Mei Sun; Stefanie Stahl; Ehud Goldin; Susan A Slaugenhaupt
Journal:  BMC Genomics       Date:  2002-02-05       Impact factor: 3.969

5.  Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases.

Authors:  Kathrin Schanda; Patrick Peschl; Magdalena Lerch; Barbara Seebacher; Swantje Mindorf; Nora Ritter; Monika Probst; Harald Hegen; Franziska Di Pauli; Eva-Maria Wendel; Christian Lechner; Matthias Baumann; Sara Mariotto; Sergio Ferrari; Albert Saiz; Michael Farrell; Maria Isabel S Leite; Sarosh R Irani; Jacqueline Palace; Andreas Lutterotti; Tania Kümpfel; Sandra Vukusic; Romain Marignier; Patrick Waters; Kevin Rostasy; Thomas Berger; Christian Probst; Romana Höftberger; Markus Reindl
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-06-15

6.  Hoxd1 is expressed by oligodendroglial cells and binds to a region of the human myelin oligodendrocyte glycoprotein promoter in vitro.

Authors:  Jayaum Booth; Danette J Nicolay; J Ronald Doucette; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 4.231

7.  Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport.

Authors:  Louise H Boyle; James A Traherne; Gemma Plotnek; Rosemary Ward; John Trowsdale
Journal:  J Neurochem       Date:  2007-06-15       Impact factor: 5.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.